ECO Animal Health Group plc (LON:EAH) has announced that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey. This was the former..
ECO Animal Health Group plc (LON:EAH) has announced that on 21 December 2023 deferred nominal cost share options were granted under the Company’s Deferred Bonus Plan (“DBS”) over 44,562 ordinary..
ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the six months ended 30 September 2023. David talks us through the highlights, the growth..
ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2023. HIGHLIGHTS Financial · Group Revenue increased 9% to £38.0 million (H1 2022: £34.9..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has received a new..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for..
ECO Animal Health Group plc (LON:EAH) Chief Executive Officer David Hallas caught up with DirectorsTalk for an exclusive interview to discuss a strong set of results, growth drivers, product markets..
ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the year ended 31st March 2023. David talks us through the highlights, explains what was..
ECO Animal Health Group pcl (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial · Revenue and adjusted EBITDA ahead of market expectations · Group sales..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be participating at..
Eco Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk Interviews to discuss interim results for the six months ended 20th September. David talks us through the highlights, improved..
ECO Animal Health Group plc (LON:EAH) the company that researches, develops and commercialises products for livestock have today published results for the six months ended 30 September 2022. HIGHLIGHTS Financials..
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that David Hallas, CEO, and Christopher..
Following a competitive tender process overseen by the Group’s Audit & Risk Committee, ECO Animal Health Group (LON:EAH) has announced the resignation of BDO LLP as auditor and the appointment,..
